Michael Sinden
@mdsinden.bsky.social
300 followers 1.1K following 32 posts
Chief Brand Officer (CBO) at @ionopticks.bsky.social LC-MS. Chromatography. Tech. Brand. Design.
Posts Media Videos Starter Packs
Reposted by Michael Sinden
ionopticks.bsky.social
With IonOpticks' rapid growth come exciting opportunities to join our expanding global team. We’re looking for passionate people who want to push the boundaries of LC-MS-based research. Ready to be part of an impact-driven company making a real difference in life sciences? Visit bit.ly/4nByJSI
mdsinden.bsky.social
I’m hiring (again)! IonOpticks’ Brand & Marketing team is growing fast. Looking for a Marketing and Creative Lead with graphic design skills who thrives across campaigns, content, sales targeting & branding. Careers page for job description: ionopticks.com/careers
Reposted by Michael Sinden
ionopticks.bsky.social
IonOpticks expands in Europe with two key appointments: Joris Frenz, PhD as BDM and Dr. Britta Diedrich as Senior BDM. Together they bring scientific and commercial expertise to support DACH/European researchers and boost access to IonOpticks’ leading LC-MS solutions. Read more.
IonOpticks strengthens European operations with key business development appointments.
MELBOURNE, AUSTRALIA | Tuesday August 26, 2025 IonOpticks, a world-leading provider of liquid chromatography solutions, today announces two strategic appointments to expand its European operations, st...
www.linkedin.com
Reposted by Michael Sinden
ionopticks.bsky.social
@matzingerm.bsky.social is co-organising #ESCP2025. As Deputy Head of the Proteomic Technology Hub at the Campus Vienna Biocenter, he’s pushing the boundaries of SCP. Manuel shares the role Aurora Series columns played in innovative methods like his lab’s One-Pot workflow: bit.ly/4eSYx86
Reposted by Michael Sinden
Reposted by Michael Sinden
ionopticks.bsky.social
IonOpticks is proud to be at #NordicMSP2025 in Odense, celebrating 50 years of MS at SDU. Meet Erik, Britta & Joris at our stand to explore how IonOpticks chromatography can level up your LC-MS workflows and push your research further with sharper, deeper insights.
Reposted by Michael Sinden
ionopticks.bsky.social
Moe Haines is transforming decades-old tissue samples into rich sources of medical knowledge. The researcher at the
@broadinstitute.org's Proteomics Platform shared how reliable chromatography has accelerated his breakthroughs in cancer and rare disease research.

Learn more: bit.ly/3JMl0d4
Reposted by Michael Sinden
ionopticks.bsky.social
@mari-mardamshin.bsky.social has seen firsthand how the loss of pancreatic function can affect someone’s life.

“Knowing that our work might one day contribute to restoring this complex organ’s function brings an added layer of meaning to what we do in the lab each day.”

Learn more: bit.ly/46ddJdS
From signals to stories: Dr. Mariya Mardamshina on decoding cells through spatial proteomic pipelines
Mariya Mardamshina M.D.
bit.ly
Reposted by Michael Sinden
ionopticks.bsky.social
Dr. Tim Veth, a postdoc working with @nmriley.bsky.social at the University of Washington, is tackling glycoproteomics. When we spoke about navigating the complexity of analysing thousands of glycoproteoforms, he shared how reliable chromatography supports his research.

Learn more: bit.ly/4nrMzad
Reposted by Michael Sinden
ionopticks.bsky.social
Join IonOpticks in Montréal next week for #MSACL2025. Zac and Erik will be on the ground at the Hôtel Bonaventure Montréal, ready to chat with you about all things chromatography. Meet them at the IonOpticks booth to see how how our new product ranges can help you elevate your LC/MS workflows.
Reposted by Michael Sinden
ionopticks.bsky.social
Our birthday, your gift: Today, we celebrate eight years of peak chromatography by inviting new users to access our industry-leading columns at rates we've never offered before.

Tell us about your setup and claim our biggest, most significant new-user discount. Ever.

Claim now: bit.ly/4nxwpwa
Reposted by Michael Sinden
ionopticks.bsky.social
"I invite all researchers to enter the glycoproteomics field and join the battle.”

With the complexity of glycoproteomics and how little we still know, Tim Veth puts out a rallying cry to speed up development in this promising field.

Learn more about Tim & read our discussion: bit.ly/3IXpo8B
Thousands of forms, one protein: how Tim Veth is deciphering the complex language of Glycans
Tim Veth, a postdoctoral researcher working with Prof. Nicholas M.
bit.ly
Reposted by Michael Sinden
ionopticks.bsky.social
We were chatting with Dr. Mike Lanz, proteomics researcher at Stanford and the Chan Zuckerberg Biohub, about his research into proteome composition and how it reflects a cell’s size and growth rate.

He also shared his experience with Aurora Series columns,

Learn more about Mike: bit.ly/3BXQRUV
Reposted by Michael Sinden
ionopticks.bsky.social
New "timePlex" method multiplexes LC-MS proteomics samples in time domain. Using IonOpticks columns + UltiMate 3000 + Orbitrap Exploris, achieved 27-fold multiplexing & >500 samples/day. 5.6x more protein IDs per run vs standard methods.

Learn more: bit.ly/3GssfWh

#Proteomics #LCMS
Increasing mass spectrometry throughput using time-encoded sample multiplexing - IonOpticks
This method for increasing mass spectrometry throughput by Derks et al. used a 25 cm x 75 um IonOpticks Aurora Ultimate 25x75 UHPLC column.
bit.ly
Reposted by Michael Sinden
ionopticks.bsky.social
It’s been a great start to the BSPR Annual Meeting 2025 in Liverpool. If you haven’t already, stop by the IonOpticks booth today, where Erik would be delighted to chat about how our new releases can elevate your proteomics workflows.
Reposted by Michael Sinden
ionopticks.bsky.social
It was great to work with omicSolution, our distributor in China, during the First Single Cell Proteomics Academic Conference in Hangzhou. Thanks to the π-HuB Project, Zhejiang University’s Department of Chemistry, & the Hangzhou International Science and Technology Innovation Center for organising.
Reposted by Michael Sinden
ionopticks.bsky.social
High-throughput spatial proteomics workflow: Klingeberg et al. develop optimised workflow using Evosep One with different Aurora Series columns coupled to a timsUltra AIP. Quantified 3,000+ proteins from 0.04 nL tissue volumes, achieving 100+ samples daily - a 3x throughput increase.

bit.ly/3GlNQ2J
An ultrasensitive spatial tissue proteomics workflow exceeding 100 proteomes per day - IonOpticks
This ultrasensitive spatial tissue proteomics workflow by Klingeberg et al. used a 5 cm x 75 um IonOpticks Aurora Rapid 5x75 CSI UHPLC column
bit.ly
Reposted by Michael Sinden
ionopticks.bsky.social
Great to attend @sciex.bsky.social's #ZenoTOF 8600 and 7500+ Roadshow at Bio21 today! Impressive sensitivity & speed with our Aurora XS columns. Tim Heymann's data: 12,000+ proteins from 200ng sample. Excited for August launch & continued @SCIEX partnership! #MassSpec #Proteomics
Reposted by Michael Sinden
ionopticks.bsky.social
"At that point, we realised we were onto something real."

Dr. Bercin Cenik had to overcome real doubt to develop TurboCas, a genetic tool that overcomes fundamental barriers in epigenetics research. Now, the method is being adopted by labs around the world.

Learn more: bit.ly/3TkEQOb
From doubt to discovery: charting new territories in epigenetics with Dr. Bercin Cenik
Bercin Cenik, a Research Assistant Professor working with Dr. Ali Shilatifard at Northwestern University's Department of Biochemistry and Molecular Genetics, is developing technologies that are tackli...
bit.ly
Reposted by Michael Sinden
ionopticks.bsky.social
We had a wonderful experience exhibiting in Japan for the first time at #AOMSC2025 in Okinawa. It was great to spend time with our distributor in the region, AMR Inc. Thanks to the organisers for bringing us together and for an outstanding program that showcased the latest innovations in the region.
Reposted by Michael Sinden
ionopticks.bsky.social
MAP-MS overcomes dynamic range limitations in Orbitrap instruments.

Using an Exploris 480 with an EASY-nLC 1200 and Aurora Ultimate XT column, Phlairaharn et al. achieved a 9% increase in protein IDs for DDA and a 4% improvement for DIA, while halving quantitative variation.

bit.ly/4dYRZWF
Improving proteomic dynamic range with Multiple Accumulation Precursor Mass Spectrometry (MAP-MS) - IonOpticks
This study into improving proteomic dynamic range by Phlairaharn et al. used a 25 cm x 75 um IonOpticks Aurora Ultimate XT 15x75 UHPLC column
bit.ly
Reposted by Michael Sinden
ionopticks.bsky.social
Every enhancement in Gen 4 Aurora Series® comes from direct collaboration with researchers.

"We work closely with researchers to understand their challenges and ensure our products address them head-on,” explains IonOpticks Chief Product Officer Dr. Jarrod Sandow.

Discover Gen 4: bit.ly/43OX6VQ
Reposted by Michael Sinden
ionopticks.bsky.social
Au revoir, Saint-Malo. It’s been an absolute pleasure getting to connect with enthusiastic proteomics researchers in front of the beachy backdrop at #EuPA2025.

Thank you to the European Proteomics Association for bringing us all together for a look at the state and future directions of proteomics.
Reposted by Michael Sinden
ionopticks.bsky.social
Researchers from the Lundberg lab have developed mxDVP, integrating high-plex microscopy with ultra-sensitive MS to explore pancreatic islet heterogeneity at unprecedented resolution.

Evosep One coupled to an Orbitrap Astral or timsTOF SCP, Aurora Elite columns on both instruments

bit.ly/3FGmeoG
Multiplexed Deep Visual Proteomics Unveils Spatial Heterogeneity and Rare Endocrine States in Human Adult Pancreatic Islets - IonOpticks
This human adult pancreatic islets study by Mardamshina et al. used a 15 cm x 75 um IonOpticks Aurora Elite XT 15x75 UHPLC column.
bit.ly
Reposted by Michael Sinden
ionopticks.bsky.social
A powerful demonstration of just what the Orbitrap Astral Zoom is capable of in Thermo's poster at #EuPA2025.

From 3,700 protein group IDs at 120 SPD (50 pg) to 6,800 protein group IDs at 50 SPD (250 pg), the combo of Orbitrap Astral Zoom + Aurora Series is already demonstrating impressive results.